Home > Financial Ratios > ONESOURCE SPECIALTY PHARMA

ONESOURCE SPECIALTY PHARMA
Core EBITDA Growth

    Back to All Ratios
ONESOURCE SPECIALTY PHARMA is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for ONESOURCE SPECIALTY PHARMA
Please provide your vote to see the results

ONESOURCE SPECIALTY PHARMA Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Growth(%) -34.04676.0846.82--

What is the latest Core EBITDA Growth ratio of ONESOURCE SPECIALTY PHARMA ?

The latest Core EBITDA Growth ratio of ONESOURCE SPECIALTY PHARMA is -34.04 based on Mar2026 Consolidated results.
Year Core EBITDA Growth
Mar2026-34.04
Mar2025676.08
Mar202446.82
Mar2023-
Mar2022-

How is Core EBITDA Growth of ONESOURCE SPECIALTY PHARMA Trending?

Years Core EBITDA Growth % Change
Mar2026 -34.04
Negative
Mar2025 676.08
1,344.00
Mar2024 46.82
0
Mar2023 0
0
Mar2022 0 -

Other Financial Ratios of ONESOURCE SPECIALTY PHARMA


Compare Core EBITDA Growth ratio of peers of ONESOURCE SPECIALTY PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ONESOURCE SPECIALTY PHARMA ₹18,325.6 Cr 1.2% 4.2% -13.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹447,476.0 Cr -0.1% -2.4% 13.8% Stock Analytics
DIVIS LABORATORIES ₹254,764.0 Cr 2.7% 12.9% 54.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹189,423.0 Cr 1.8% 2.5% 40.9% Stock Analytics
CIPLA ₹111,484.0 Cr 0.6% -3.8% -11.4% Stock Analytics
DR REDDYS LABORATORIES ₹101,005.0 Cr 3.3% 1.3% -7.6% Stock Analytics


ONESOURCE SPECIALTY PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ONESOURCE SPECIALTY PHARMA

1.2%

4.2%

-13.7%

SENSEX

0.7%

-3.5%

-9.2%


You may also like the below Video Courses